Iain Buchanan, 

Biography

  Member of the Advisory Board Iain Buchanan was appointed to the Allecra Therapeutics Advisory Board upon its formation in 2013 and brings to the company over 40 years’ experience in the Pharmaceutical and Biotech industries. Iain was Chief Executive Officer of Novexel S.A. in Paris from its creation as the anti-infective spin out of Sanofi-Aventis in 2004 until its sale in 2009. Previously, he held a variety of management positions including positions in Vertex Pharmaceuticals (Europe) Limited, Cilag A.G. and in Biogen S.A. Iain holds a Bachelor of Science in Physiology from the University of St. Andrews, Scotland and is a non-executive director of Synairgen plc

Research Interest

Bioinformatics & Systems Biology